| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-11 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.68 | 7e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |